On the contrary, women delay fertility in response to economic insecurity at the individual level, but make fertility precarious when they observe uncertainty at the macro level. Since the case also concerned the allegation that GSK had abused its dominant position by concluding the concord agreements, the CAT also asked a question on the definition of the relevant market in order to determine whether GSK held a dominant position. In particular, the CAT asked whether generic medicines should be included on the relevant product market of the patented medicine, given that the patent for the active substance has expired, but the process patents remain valid. Not surprisingly, the Court`s analysis paralleled its analysis of potential competition. . . .